Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Alto Neuroscience (NYSE:ANRO) through any online brokerage.
Other companies in Alto Neuroscience’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), Zevra Therapeutics Inc (NASDAQ:ZVRA), GH Research PLC (NASDAQ:GHRS), AtaiBeckley Inc (NASDAQ:ATAI) and Bioage Labs Inc (NASDAQ:BIOA).
Alto Neuroscience has a consensus price target of $28.55.
The stock price for Alto Neuroscience (NYSE: ANRO) is $27.9 last updated April 17, 2026 at 7:50 PM EDT.
There are no upcoming dividends for Alto Neuroscience.
Alto Neuroscience does not have any upcoming earnings scheduled.
There is no upcoming split for Alto Neuroscience.
Alto Neuroscience is in the Health Care sector and Pharmaceuticals industry. They are listed on the NYSE.